Thomson Reuters Prous Science, a Thomson Reuters business
Clinical Medicine
Prous Science Solutions
September 2, 2010
ISMC 2010
Molecule of the Month Molecule of the Month
This month: the guanylate cyclase C (GC-C) activator linaclotide acetate, a promising treatment for constipation and IBS
The Cutting Edge of Chemistry Thomson Reuters Drug News
The Cutting Edge of Chemistry
THE CUTTING EDGE OF CHEMISTRY
Free quarterly report from Thomson Reuters

An action-packed review of the latest chemistry shaping today's drug discovery and development pipeline
 
Thomson Reuters Drug NewsDailyDrugNews.com is now
Thomson Reuters Drug News
Get the same Drug R&D News you expect, enhanced navigation and integration
Find out more
More
Images & Pathways ISCP Cardio
Canakinumab
Canakinumab -
Mechanism of Action

An animation depicting the mechanism of action of the anti-IL-1beta recombinant human monoclonal antibody canakinumab.
 
ISCP CardioInternational Society Cardiovascular Pharmacotherapy
The ISCP is a society devoted to education and medical research in the field of cardiovascular pharmacotherapy, as well as to the international exchange of information and to the needs of cardiovascular pharmacotherapy with special focus on developing countries.
Thomson Reuters Drug News
Discover new information presented at recent conferences, including:
(for subscribers only)
13th World Congress on Pain (August 29-September 2, Montreal)
European Society of Cardiology Congress (August 28-September 1, Stockholm )
23rd Congress of the European College of Neuropsychopharmacology (ECNP) (August 28-September 1, Amsterdam )
35th Joint Annual Meeting of the International Continence Society (ICS) and International Urogynecological Association (IUGA) (August 23-27, Toronto)
To obtain subscription information, please click here
What's New What's New

Drugs of Today
Peramivir is a new potent neuramidase inhibitor approved by U.S. Emergency Use Authorization (EUA) for the treatment of patients infected with 2009 H1N1 influenza virus.

Drug News & Perspectives
Biomedical exploitation of the fungus-growing ant symbiosis. Despite the prevalence and importance of symbioses, they have remained largely unexplored for natural products.

Add RSS Headlines
Copyright © 2010 Prous Science S.A.U. or its licensors.
All rights reserved. Legal Information.
Send your comments to Webmaster.